The Cooper Companies, Inc. (COO)
NASDAQ: COO · Real-Time Price · USD
82.92
+1.67 (2.06%)
May 8, 2025, 4:00 PM EDT - Market closed
Revenue by Product
Fiscal year is November - October.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | NaN - NaN |
| Toric Lens | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Toric Lens Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Multifocal Lens | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Multifocal Lens Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Toric and Multifocal | 1.28B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Toric and Multifocal Growth | 9.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Single-Use Sphere Lens | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Single-Use Sphere Lens Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Non Single-Use Sphere Lens and Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Non Single-Use Sphere Lens and Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sphere, Other | 1.35B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sphere, Other Growth | 4.71% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total CooperVision | 2.63B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total CooperVision Growth | 6.90% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total CooperSurgical | 1.29B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total CooperSurgical Growth | 7.66% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Office and Surgical Products | 782.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Office and Surgical Products Growth | 9.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Fertility | 512.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Fertility Growth | 5.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is November - October.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | NaN - NaN |
| CooperVision Operating Income | 705.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| CooperVision Operating Income Growth | 21.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| CooperSurgical Operating Income | 114.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| CooperSurgical Operating Income Growth | 233.82% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Operating Income | -85.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Operating Income Growth | 6.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is November - October.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | NaN - NaN |
| United States | 1.99B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 7.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 1.17B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 9.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest Of The World | 769.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest Of The World Growth | 2.79% |
Log In |
Log In |
Log In |
Log In | Upgrade
|